Using Cerebrospinal Fluid Nanopore Sequencing Assay to Diagnose Tuberculous Meningitis: a Retrospective Cohort Study in China
Overview
Authors
Affiliations
Objective: This study aimed to evaluate the efficiency of nanopore sequencing for the early diagnosis of tuberculous meningitis (TBM) using cerebrospinal fluid and compared it with acid-fast bacilli (AFB) smear, mycobacterial growth indicator tube culture and Xpert (MTB)/rifampicin (RIF).
Design: Single-centre retrospective study.
Setting: The Tuberculosis Diagnosis and Treatment Center of Zhejiang Chinese and Western Medicine Integrated Hospital.
Participants: We enrolled 64 adult patients with presumptive TBM admitted to our hospital from August 2021 to August 2023.
Methods: We calculated the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of AFB smear, culture, Xpert MTB/RIF and nanopore sequencing to evaluate their diagnostic efficacy compared with a composite reference standard for TBM.
Results: Among these 64 patients, all tested negative for TBM by AFB smear. The sensitivity, specificity, PPV and NPV were 11.11%, 100%, 100% and 32.2% for culture, 13.33%, 100%, 100% and 2.76% for Xpert MTB/RIF, and 77.78%, 100%, 100% and 65.52% for nanopore sequencing, respectively.
Conclusion: The diagnostic accuracy of the nanopore sequencing test was significantly higher than that of conventional testing methods used to detect TBM.
Oo N, Agrawal D Arch Intern Med Res. 2025; 8(1):48-58.
PMID: 40061519 PMC: 11887623. DOI: 10.26502/aimr.0195.
Nanopore-targeted sequencing (NTS) for intracranial tuberculosis: a promising and reliable approach.
Yang C, Wang T, Guo Y, Zeng Y, Gao W Ann Clin Microbiol Antimicrob. 2024; 23(1):89.
PMID: 39385187 PMC: 11466032. DOI: 10.1186/s12941-024-00751-x.